Evidence map›Paper›PMID 35585568›Full record

ArticleBMC nephrology2022

Association of acute kidney disease with the prognosis of ischemic stroke in the Third China National Stroke Registry.

Yilun Zhou, Dongxue Wang, Hao Li, Yuesong Pan, Xianglong Xiang, Yu Wu, Xuewei Xie, Xianwei Wang, Yang Luo, Xia Meng and 7 more

Abstract read
In one paragraph

Article in BMC nephrology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Research progress in the relationship between gut microbiota metabolite trimethylamine N-oxide and ischemic stroke.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Yilun Zhou *Department of Nephrology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Dongxue Wang *Department of Nephrology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Hao LiChina National Clinical Research Center for Neurological Diseases, Beijing, China.
Yuesong PanChina National Clinical Research Center for Neurological Diseases, Beijing, China.
Xianglong XiangChina National Clinical Research Center for Neurological Diseases, Beijing, China.
Yu WuDepartment of Nephrology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Xuewei XieChina National Clinical Research Center for Neurological Diseases, Beijing, China.
Xianwei WangCenter for Metabolic Disease Research, Lewis Kats School of Medicine, Temple University, Philadelphia, USA.
Yang LuoDepartment of Nephrology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Xia MengChina National Clinical Research Center for Neurological Diseases, Beijing, China.
Jinxi LinChina National Clinical Research Center for Neurological Diseases, Beijing, China.
Hong WangCenter for Metabolic Disease Research, Lewis Kats School of Medicine, Temple University, Philadelphia, USA.
Yong HuoDepartment of Cardiology, Peking University First Hospital, Beijing, China.
Kunihiro MatsushitaJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Jing ChenDepartment of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA.
Fan Fan HouNational Clinical Research Center for Kidney Disease, Nanfang Hospital, Southern Medical University, Guangzhou, China. ffhouguangzhou@163.com.
Yongjun WangChina National Clinical Research Center for Neurological Diseases, Beijing, China. yongjunwang@ncrcnd.org.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcute kidney disease (AKD) evolves a spectrum of acute and subacute kidney disease requiring a global strategy to address. The present study aimed to explore the impact of AKD on the prognosis of ischemic stroke.

methodsThe Third China National Stroke Registry (CNSR-III) was a nationwide registry of ischemic stroke or transient ischemic attack between August 2015 and March 2018. As a subgroup of CNSR-III, the patients who had serum creatinine (sCr) and serum cystatin C (sCysC) centrally tested on admission and at 3-month, and with 1-year follow-up data were enrolled. Modified AKD criteria were applied to identify patients with AKD during the first 3 months post stroke according to the guidelines developed by the Kidney Disease: Improving Global Outcomes in 2012. The primary clinical outcome was 1-year all-cause death, and secondary outcomes were stroke recurrence and post stroke disability.

resultsFive thousand sixty-five patients were recruited in the study. AKD was identified in 3.9%, 6.7%, 9.9% and 6.2% of the patients by using sCr, sCr-based estimated glomerular filtration rate (eGFR

conclusionsAKD, diagnosed by sCr or eGFR

Indexed as

Ischemic StrokeKidney DiseasesStrokeAcute DiseaseBiomarkersChinaGlomerular Filtration RateHumansPrognosisRegistriesBiomarkersAcute kidney diseaseIncidenceMortalityPrognosisStroke

Identifiers

PMID35585568
PMCPMC9115968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.